These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 4267969)

  • 1. Effects of pretreatment with spironolactone on pharmacokinetics of 4'''-methyldigoxin in rats.
    Abshagen U
    Naunyn Schmiedebergs Arch Pharmacol; 1973; 278(1):91-100. PubMed ID: 4267969
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of pretreatment with spironolactone of pharmacokinetics of 4'''-methyldigoxin in man.
    Abshagen U; Rennekamp H; Kuhlmann J
    Naunyn Schmiedebergs Arch Pharmacol; 1976; 292(1):87-92. PubMed ID: 934358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative analysis of digoxin, 4'''-acetyldigoxin and 4'''-methyldigoxin and their metabolites in bile and urine of rats.
    von Bergmann K; Abshagen U; Rietbrock N
    Naunyn Schmiedebergs Arch Pharmacol; 1972; 273(1):154-67. PubMed ID: 4260800
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacokinetics of digoxin and its 4'''-acetyl- and methylderivates in the rat.
    Rietbrock N; Abshagen U; von Bergmann K; Kewitz H
    Naunyn Schmiedebergs Arch Pharmacol; 1972; 274(2):171-81. PubMed ID: 4262277
    [No Abstract]   [Full Text] [Related]  

  • 5. H3-digitoxin and its metabolites following spironolactone pretreatment of rats.
    Castle MC; Lage GL
    Res Commun Chem Pathol Pharmacol; 1973 Sep; 6(2):601-12. PubMed ID: 4750104
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of spironolactone on excretion of 3H-digoxin and its metabolites in rats.
    Wirth KE; Frölich JC
    Eur J Pharmacol; 1974 Nov; 29(1):43-51. PubMed ID: 4435043
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation of the enterohepatic circulation after 3 H-digoxin administration in the rat.
    Abshagen U; von Bergmann K; Rietbrock N
    Naunyn Schmiedebergs Arch Pharmacol; 1972; 275(1):1-10. PubMed ID: 4264167
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacokinetic behaviour of 4'''-methyldigoxin in man.
    Rennekamp H; Rennekamp C; Abshagen U; von Bergmann K; Rietbrock N
    Naunyn Schmiedebergs Arch Pharmacol; 1972; 273(1):172-4. PubMed ID: 4260801
    [No Abstract]   [Full Text] [Related]  

  • 9. Digoxin-interactions in man: spironolactone reduces renal but not biliary digoxin clearance.
    Hedman A; Angelin B; Arvidsson A; Dahlqvist R
    Eur J Clin Pharmacol; 1992; 42(5):481-5. PubMed ID: 1606994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Demethylation and cleavage of glycosidic bonds of 4'''-methyldigoxin in man.
    Rietbrock N; Rennekamp C; Rennekamp H; von Bergmann K; Abshagen U
    Naunyn Schmiedebergs Arch Pharmacol; 1972; 272(4):450-3. PubMed ID: 4260266
    [No Abstract]   [Full Text] [Related]  

  • 11. Spironolactone-induced changes in digoxin kinetics.
    Waldorff S; Andersen JD; Heebøll-Nielsen N; Nielsen OG; Moltke E; Sørensen U; Steiness E
    Clin Pharmacol Ther; 1978 Aug; 24(2):162-7. PubMed ID: 679595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of spironolactone pretreatment on pharmacokinetics and metabolism of digitoxin in rats.
    VOHRINGER HF; Weller L; Rietbrock N
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 287(2):129-39. PubMed ID: 1143356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. -methyl-digoxin. IV. Blood levels, tissue distribution and metabolism in the guinea-pig.
    Voigtländer W; Schaumann W; Koch K; Zielske F
    Naunyn Schmiedebergs Arch Pharmacol; 1972; 272(1):46-64. PubMed ID: 4257471
    [No Abstract]   [Full Text] [Related]  

  • 14. [Study of the intestinal absorption of beta-methyldigoxin].
    Larbig D; Scheler F; Schmidt HJ; Betzien G; Kaufmann B
    Klin Wochenschr; 1971 May; 49(10):604-7. PubMed ID: 5578966
    [No Abstract]   [Full Text] [Related]  

  • 15. Tissue distribution and elimination of digoxin and methyldigoxin after single and multiple doses in dogs.
    Kuhlmann J; Rietbrock N; Schnieders B
    J Cardiovasc Pharmacol; 1979; 1(2):219-34. PubMed ID: 94391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Digoxin-quinidine-spironolactone interaction.
    Fenster PE; Hager WD; Goodman MM
    Clin Pharmacol Ther; 1984 Jul; 36(1):70-3. PubMed ID: 6734052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of microsomal enzyme inducers on the biliary excretion of cardiac glycosides.
    Klaassen CD
    J Pharmacol Exp Ther; 1974 Nov; 191(2):201-11. PubMed ID: 4418514
    [No Abstract]   [Full Text] [Related]  

  • 18. [The effects of diphenylhydantoin and spironolactone on the digoxin pharmacokinetics in the rabbit (author's transl)].
    Tato F; Pérez Fontán J; Lloveres J
    Arch Farmacol Toxicol; 1980 Aug; 6(2):151-60. PubMed ID: 7469497
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacokinetics of beta-methyldigoxin in healthy humans IV: comparisons of radioimmunoassays, total radioactivity, and specific assays of beta-methyldigoxin and digoxin in plasma.
    Garrett ER; Hinderling PH
    J Pharm Sci; 1977 Jun; 66(6):806-10. PubMed ID: 874780
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of spironolactone and canrenone on the digoxin radioimmunoassay.
    Huffman DH
    Res Commun Chem Pathol Pharmacol; 1974 Dec; 9(4):787-90. PubMed ID: 4477402
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.